Abstract:Several factors play a role in obesity (i.e., behavior, environment, and genetics) and epigenetic regulation of gene expression has emerged as a potential contributor in the susceptibility and development of obesity. To investigate the individual sensitivity to weight gain/resistance, we here studied gene transcription regulation of several hypothalamic neuropeptides involved in the control of energy balance in rats developing obesity (diet-induced obesity, DIO) or not (diet resistant, DR), when fed with a hig… Show more
“…We have subsequently investigated whether EM66 expression within the hypothalamus is influenced by the energy status of the animal, and we have compared it with the gene expression of POMC and NPY in diet‐induced obesity and in fasting conditions. Our results reveal that long‐term HFD exposure is associated with an important decrease in POMC mRNA levels and no significant change in NPY gene expression, in agreement with previous studies . Concurrently, we show that expression of SgII (the EM66 precursor) is down‐regulated in HFD mice to a similar extent as POMC, suggesting that EM66 is a major anorexigenic factor playing a crucial role in the maintenance of the obese status, acting in synergy with α‐MSH (the anorexigenic POMC‐derived peptide).…”
EM66 is a conserved 66-amino acid peptide derived from secretogranin II (SgII), a member of the granin protein family. EM66 is widely distributed in secretory granules of endocrine and neuroendocrine cells, as well as in hypothalamic neurones. Although EM66 is abundant in the hypothalamus, its physiological function remains to be determined. The present study aimed to investigate a possible involvement of EM66 in the hypothalamic regulation of feeding behaviour. We show that i.c.v. administration of EM66 induces a drastic dose-dependent inhibition of food intake in mice deprived of food for 18 hours, which is associated with an increase of hypothalamic pro-opiomelanocortin (POMC) and melanocortin-3 receptor mRNA levels and c-Fos immunoreactivity in the POMC neurones of the arcuate nucleus. By contrast, i.c.v. injection of EM66 does not alter the hypothalamic expression of neuropeptide Y (NPY), or that of its Y1 and Y5 receptors. A 3-month high-fat diet (HFD) leads to an important decrease of POMC and SgII mRNA levels in the hypothalamus, whereas NPY gene expression is not affected. Finally, we show that a 48 hours of fasting in HFD mice decreases the expression of POMC and SgII mRNA, which is not observed in mice fed a standard chow. Taken together, the present findings support the view that EM66 is a novel anorexigenic neuropeptide regulating hypothalamic feeding behaviour, at least in part, by activating the POMC neurones of the arcuate nucleus.
“…We have subsequently investigated whether EM66 expression within the hypothalamus is influenced by the energy status of the animal, and we have compared it with the gene expression of POMC and NPY in diet‐induced obesity and in fasting conditions. Our results reveal that long‐term HFD exposure is associated with an important decrease in POMC mRNA levels and no significant change in NPY gene expression, in agreement with previous studies . Concurrently, we show that expression of SgII (the EM66 precursor) is down‐regulated in HFD mice to a similar extent as POMC, suggesting that EM66 is a major anorexigenic factor playing a crucial role in the maintenance of the obese status, acting in synergy with α‐MSH (the anorexigenic POMC‐derived peptide).…”
EM66 is a conserved 66-amino acid peptide derived from secretogranin II (SgII), a member of the granin protein family. EM66 is widely distributed in secretory granules of endocrine and neuroendocrine cells, as well as in hypothalamic neurones. Although EM66 is abundant in the hypothalamus, its physiological function remains to be determined. The present study aimed to investigate a possible involvement of EM66 in the hypothalamic regulation of feeding behaviour. We show that i.c.v. administration of EM66 induces a drastic dose-dependent inhibition of food intake in mice deprived of food for 18 hours, which is associated with an increase of hypothalamic pro-opiomelanocortin (POMC) and melanocortin-3 receptor mRNA levels and c-Fos immunoreactivity in the POMC neurones of the arcuate nucleus. By contrast, i.c.v. injection of EM66 does not alter the hypothalamic expression of neuropeptide Y (NPY), or that of its Y1 and Y5 receptors. A 3-month high-fat diet (HFD) leads to an important decrease of POMC and SgII mRNA levels in the hypothalamus, whereas NPY gene expression is not affected. Finally, we show that a 48 hours of fasting in HFD mice decreases the expression of POMC and SgII mRNA, which is not observed in mice fed a standard chow. Taken together, the present findings support the view that EM66 is a novel anorexigenic neuropeptide regulating hypothalamic feeding behaviour, at least in part, by activating the POMC neurones of the arcuate nucleus.
“…In the studies evaluated herein, no methylation changes were observed for NPY, MC4R, or PPAR-γ when investigated (Cifani et al, 2015;Zheng et al, 2015), while the methylation status of POMC was consistently found to be altered and positively associated with increased levels of leptin and insulin and the development of the obesity phenotype and symptoms of MeS (Cifani et al, 2015;Gali Ramamoorthy et al, 2018;Marco et al, 2013;Andreas Plagemann et al, 2009;Wang et al, 2014;Zhang et al, 2014;Zheng et al, 2015).…”
Section: P Om C Me Thyl Ati On and Ob E S It Ymentioning
confidence: 68%
“…In the studies evaluated herein, no methylation changes were observed for NPY , MC4R, or PPAR‐ γ when investigated (Cifani et al, ; Zheng et al, ), while the methylation status of POMC was consistently found to be altered and positively associated with increased levels of leptin and insulin and the development of the obesity phenotype and symptoms of MeS (Cifani et al, ; Gali Ramamoorthy et al, ; Marco et al, ; Andreas Plagemann et al, ; Wang et al, ; Zhang et al, ; Zheng et al, ). With POMC‐mediated leptin and insulin function playing a major role in the pathological development of obesity and MeS, the methylation status of POMC thus represents a pivotal therapeutic target.…”
Section: Pomc Methylation and Obesitymentioning
confidence: 92%
“…After 21 weeks of HFD‐feeding, no changes in NPY or AgRP expression level between the respective groups were observed, while a reduced expression of POMC within the DIO group was reported when compared to the diet resistant group. Furthermore, no changes in NPY methylation were observed, while POMC promoter methylation was reduced in diet resistant group compared with the DIO group (Cifani et al, ). These studies provide evidence for obesogenic diet‐induced alteration in DNA methylation of arcuate nucleus genes, such as POMC , which were associated with raised leptin and insulin levels and the development of obesity and MeS (Cifani et al, ; Marco et al, ).…”
Section: Diet‐induced Dna Methylation Within the Arcuate Nucleusmentioning
Obesity rates continue to rise in an unprecedented manner in what could be the most rapid population‐scale shift in human phenotype ever to occur. Increased consumption of unhealthy, calorie‐dense foods, coupled with sedentary lifestyles, is the main factor contributing to a positive energy balance and the development of obesity. Leptin and insulin are key hormones implicated in pathogenesis of this disorder and are crucial for controlling whole‐body energy homeostasis. Their respective function is mediated by the counterbalance of anorexigenic and orexigenic neurons located within the hypothalamic arcuate nucleus. Dysregulation of leptin and insulin signaling pathways within this brain region may contribute not only to the development of obesity, but also systemically affect the peripheral organs, thereby manifesting as metabolic diseases. Although the exact mechanisms detailing how these hypothalamic nuclei contribute to disease pathology are still unclear, increasing evidence suggests that altered DNA methylation may be involved. This review evaluates animal studies that have demonstrated diet‐induced DNA methylation changes in genes that regulate energy homeostasis within the arcuate nucleus, and elucidates possible mechanisms causing hypothalamic leptin and insulin resistance leading to the development of obesity and metabolic diseases.
“…The increase in POMC and NPY expression detected in the brains of E18 pups taken from dams fed a high fat diet is somewhat paradoxical. Indeed, one would expect that POMC expression would be decreased as it does in adult animals that are chronically exposed to high fat diets (Cifani et al, 2015; Desai et al, 2016). Nevertheless, our data are consistent with data of others showing that rat pups whose mother was exposed to a high fat diet showed increased POMC and NPY mRNA expression in the ARC twenty days after birth (Chen and Morris, 2009).…”
Developmental programing is influenced by perinatal nutrition and it has long-lasting impacts on adult metabolism in the offspring. In particular, maternal high fat diet has been associated with increased risk of obesity and metabolic disorders during adulthood in the descendants. These effects may be due to the effects of the high fat diet on the development of the systems that regulate food intake and energy balance in the offspring hypothalamus. The arcuate nucleus (ARC) may be a particularly sensitive region to it as this nucleus contains the POMC and AgRP/NPY neurons that integrate the melanocortin system. Thus, the aim of this study was to investigate the effects of maternal high fat diet during pregnancy on the transcription factors that regulate hypothalamic development in the offspring as a potential mechanism that may result in altered neuronal expression of POMC, NPY and/or AgRP. To this end, pregnant females exposed to high fat diet (60% fat diet since day 0 of pregnancy) or standard rat chow were sacrificed on days 12, 14, 16 and 18 of gestation to obtain brains from their developing fetuses and examine the mRNA expression of transcription factors associated with the development of cells in the ARC. Results show that, while no changes in transcription factor expression between groups were observed, POMC and NPY mRNA expression were higher on embryonic day 18 in the high fat group. These results suggest that POMC and NPY expression are altered by in utero exposure to a high fat diet, but these changes in gene expression are not associated with changes in the expression of transcription factors known to determine the fate of ARC cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.